Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 45 of 201

Innovations in CLINICAL NEUROSCIENCE [ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] 46 Rating Scale (C-SSRS): Has the "Gold Standard" become a liability? Innov Clin Neurosci. 2014;11(9–10):66–80. 9. Meyer RE, Salzman C, Youngstrom EA, et al. Suicidality and risk of suicide: definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010;71(8):e1–e21. 10. Gassmann-Mayer C, Jiang K, McSorley P, et al. Clinical and statistical assessment of suicidal ideation and behavior in pharmaceutical trials. Clin Pharmacol Ther. 2011;90(4):554–560. 11. Coric V, Stock EG, Pultz J, et al. Sheehan-Suicidality Tracking Scale (S-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont). 2009;1(6): 26–31. 12. Preti A, Sheehan DV, Coric V, et al. Sheehan Suicidality Tracking Scale (S-STS): reliability, convergent, and discriminative validity in young Italian adults. Compr Psychiatry. 2013;54(7):842–849. 13. Sheehan DV, Giddens JM, Sheehan IS. Status Update on the Sheehan- Suicidality Tracking Scale (S-STS) 2014. Innov Clin Neurosci. 2014;11(9–10):93–140. 14. Lindenmayer JP, InterSePT Study Group, Czobor P, et al. The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res. 2003;63(1–2):161–170. 15. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46. 16. Shrout PE, Spitzer R, Fleiss JL. Quantification of agreement in psychiatric diagnosis revisted. Arch Gen Psychiatry. 1987;44(2): 172–177. 17. Fleiss HJL, Statistical Methods for Rates and Proportions, Second Edition. New York, NY: John Wiley & Sons, 1981. 18. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46(5):423–429. 19. Kessler RC, Akiska HS, Angst J, et al. Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord. 2006;96(3):259–269. 20. Agresti A. Categorical Data Analysis, Second Edition. Hoboken, NJ: John Wiley & Sons, Inc; 2002. 21. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60(2):184–189. 22. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. 23. Giddens JM, Sheehan DV. Is there any value in asking the question "Do you think you would be better off dead?" in assessing suicide? Innov Clin Neurosci. 2014;11(9–10):182–190. TABLE 7. Time taken to administer each scale (N=34) SCALE DURATION IN MINUTES AND SECONDS (MEAN±SD) C-SSRS 8:13±3:08 ISST-Plus 14:54±10:23 S -STS S-STS patient-rated S-STS clinician-rated S-STS reconciliation (34 needing reconciliation) 8:35±4:47 9:13±6:14 2:51±1:28 SD: standard deviation; C–SSRS: Columbia–Suicide Severity Rating Scale; ISST-Plus: InterSePT Scale for Suicidal Thinking-Plus; S-STS: Sheehan-Suicidality Tracking Scale

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014